CCI approves acquisition of stake in Asian Institute of Nephrology and Urology by TPG Growth V SF Markets, Waverly through Asia Healthcare Holdings
New Delhi: The Competition Commission of India (CCI) has approved acquisition of stake in Asian Institute of Nephrology and Urology Private Limited by TPG Growth V SF Markets Pte. Ltd. and Waverly Pte. Ltd. through Asia Healthcare Holdings Pte. Ltd.
The proposed combination relates to (a) the acquisition of fresh Redeemable Preference Shares (New RPS) in Asia Healthcare Holdings Pte. Ltd. (AHH) by TPG Growth V SF Markets Pte. Ltd. (Growth V) and Waverly Pte. Ltd. (Waverly) (Part I), and (b) subsequent acquisition of majority shareholding in Asian Institute of Nephrology and Urology Private Limited (AINU) by AHH (Part II).
Growth V is an investment fund that is ultimately managed and controlled by TPG Inc. (TPG), which is a global, diversified investment firm. TPG is the ultimate holding company of the TPG Group, which operates through multiple strategies including buyout/control situations, growth & technology investing, and impact investing (including climate) across multiple sectors such as financial services, technology, consumer, travel, media, real estate, and healthcare. The TPG Group also has a controlling stake in NewQuest Capital, another private equity investment firm having investments across multiple sectors such as financial services, travel, and real estate.
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.